Epigenome-wide association study of chronic obstructive pulmonary disease and lung function in Koreans

Epigenomics

Volumn 9, Issue 7, 2017, Pages 971-984

  Lee, Mi Kyeong ^a,b   Hong, Yoonki ^b   Kim, Sun Young ^c   Kim, Woo Jin ^b   London, Stephanie J ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b Kangwon National University   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

chronic obstructive pulmonary disease; DNA methylation; epigenome wide association study; gene expression; lung function

Indexed keywords

DNA; TRANSCRIPTOME;

AGED; ARTICLE; BHMT GENE; CD300A GENE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CPG ISLAND; CPT1B GENE; CTU2 GENE; DNA METHYLATION; EPIGENETICS; FAM196A GENE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE; GENE EXPRESSION; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC TRAIT; GENOME-WIDE ASSOCIATION STUDY; HLA C GENE; HUMAN; KLK10 GENE; KOREAN (PEOPLE); LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; POPULATION GENETICS; PRIORITY JOURNAL; SPIROMETRY; SRPRB GENE; TRANSCRIPTOMICS; USP36 GENE; ZC3H3 GENE; ZNF516 GENE; CASE CONTROL STUDY; GENE LOCUS; GENETIC EPIGENESIS; GENETICS; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENETIC LOCI; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 85021729996     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi-2017-0002     Document Type: Article

References (58)

1. Schunemann HJ, Dorn J, Grant BJ, Winkelstein W, Jr., Trevisan M. Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest 118(3), 656-664 (2000).
2. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 370(9589), 765-773 (2007).
3. Koshiol J, Rotunno M, Consonni D et al. Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study. PLoS ONE 4(10), e7380 (2009).
4. Carrasco Garrido P, De Miguel Diez J, Rejas Gutierrez J et al. Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study. Health Qual. Life Outcomes 4, 31 (2006).
5. Loth DW, Soler Artigas M, Gharib SA et al. Genome-wide association analysis identifies six new loci associated with forced vital capacity. Nat. Genet. 46(7), 669-677 (2014).
6. Cho MH, Castaldi PJ, Wan ES et al. A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13. Hum. Mol. Genet. 21(4), 947-957 (2012).
7. Boezen HM, Mannino DM. The future of nature versus nurture in understanding chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 188(8), 891-892 (2013).
8. Yoo S, Takikawa S, Geraghty P et al. Integrative analysis of DNA methylation and gene expression data identifies EPAS1 as a key regulator of COPD. PLoS Genet. 11(1), e1004898 (2015).
9. Qiu W, Baccarelli A, Carey VJ et al. Variable DNA methylation is associated with chronic obstructive pulmonary disease and lung function. Am. J. Respir. Crit. Care Med. 185(4), 373-381 (2012).
10. Vucic EA, Chari R, Thu KL et al. DNA methylation is globally disrupted and associated with expression changes in chronic obstructive pulmonary disease small airways. Am. J. Respir. Cell Mol. Biol. 50(5), 912-922 (2014).
11. Morrow JD, Cho MH, Hersh CP et al. DNA methylation profiling in human lung tissue identifies genes associated with COPD. Epigenetics doi:10.1080/15592294.2016.1226451 (2016) (Epub ahead of print).
12. Busch R, Qiu W, Lasky-Su J, Morrow J, Criner G, Demeo D. Differential DNA methylation marks and gene comethylation of COPD in African-Americans with COPD exacerbations. Respir. Res. 17(1), 143 (2016).
13. Lister R, Pelizzola M, Dowen RH et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462(7271), 315-322 (2009).
14. Jaffe AE, Murakami P, Lee H et al. Bump hunting to identify differentially methylated regions in epigenetic epidemiology studies. Int. J. Epidemiol. 41(1), 200-209 (2012).
15. Kim WJ, Hong Y. Methodology of an observational cohort study for subjects with chronic obstructive pulmonary disease in dusty areas near cement plants. J. Pulm. Respir. Med. 04(01), 169-174 (2014).
16. Global Initiative for Chronic Obstructive Lung Disease. Global stregaty for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2016). http://goldcopd.org
17. Ji W, Lim MN, Bak SH et al. Differences in chronic obstructive pulmonary disease phenotypes between nonsmokers and smokers. Clin. Respir. J. doi:10.1111/crj.12577 (2016) (Epub ahead of print).
18. Teschendorff AE, Marabita F, Lechner M et al. A betamixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data. Bioinformatics 29(2), 189-196 (2013).
19. Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8(1), 118-127 (2007).
20. Nordlund J, Backlin CL, Wahlberg P et al. Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia. Genome Biol. 14(9), r105 (2013).
21. Morris TJ, Butcher LM, Feber A et al. ChAMP: 450k chip analysis methylation pipeline. Bioinformatics 30(3), 428-430 (2014).
22. Price ME, Cotton AM, Lam LL et al. Additional annotation enhances potential for biologically-relevant analysis of the Illumina Infinium HumanMethylation450 BeadChip array. Epigenetics Chromatin 6(1), 4 (2013).
23. What are outliers in the data? www.itl.nist.gov
24. Houseman EA, Accomando WP, Koestler DC et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics 13, 86 (2012).
25. Reinius LE, Acevedo N, Joerink M et al. Differential DNA methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility. PLoS ONE 7(7), e41361 (2012).
26. Peters TJ, Buckley MJ, Statham AL et al. De novo identification of differentially methylated regions in the human genome. Epigenetics Chromatin 8, 6 (2015).
27. Pedersen BS, Schwartz DA, Yang IV, Kechris KJ. Comb-p: software for combining, analyzing, grouping and correcting spatially correlated p-values. Bioinformatics 28(22), 2986-2988 (2012).
28. Benjamini Y, Hochberg Y. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J. R. Stat. Soc. Series. B Stat. Methodol. 57(1), 289-300 (1995).
29. Sidak Z. Rectangular confidence regions for the means of multivariate normal distributions. J. Am. Stat. Assoc. 62(318), 8 (1967).
30. Peters T. Package 'DMRcate' (2016).
31. Kent WJ, Sugnet CW, Furey TS et al. The human genome browser at UCSC. Genome Res. 12(6), 996-1006 (2002).
32. UCSC Genome Browser. http://genome.ucsc.edu
33. Martin TC, Yet I, Tsai PC, Bell JT. coMET: visualisation of regional epigenome-wide association scan results and DNA co-methylation patterns. BMC Bioinformatics 16, 131 (2015).
34. Roadmap Epigenomics Visualization Hub (VizHub). http://vizhub.wustl.edu/
35. Consortium EP. An integrated encyclopedia of DNA elements in the human genome. Nature 489(7414), 57-74 (2012).
36. Consortium GT. The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 45(6), 580-585 (2013).
37. Illumina I. Illumina Infinium HumanMethylation450 BeadChip Annotation. https://support.illumina.com
38. Kim WJ, Lim JH, Lee JS, Lee SD, Kim JH, Oh YM. Comprehensive analysis of transcriptome sequencing data in the lung tissues of COPD subjects. Int. J. Genomics 2015, 206937 (2015).
39. R Foundation for Statistical Computing. R: A language and environment for statistical computing (2013). www.gbif.org/resource/81287
40. Integrative analysis of complex cancer genomics and clinical profiles. www.cbioportal.org/beta/index.do
41. Kumar M, Bhadoria DP, Dutta K et al. Combinatorial effect of TIMP-1 and alpha1AT gene polymorphisms on development of chronic obstructive pulmonary disease. Clin. Biochem. 44(13), 1067-1073 (2011).
42. Perez-Rubio G, Jimenez-Valverde LO, Ramirez-Venegas A et al. Prevalence of alpha-1 antitrypsin high-risk variants in Mexican mestizo population and their association with lung function values. Arch. Bronconeumol. 51(2), 80-85 (2015).
43. Jackson VE, Ntalla I, Sayers I et al. Exome-wide analysis of rare coding variation identifies novel associations with COPD and airflow limitation in MOCS3, IFIT3 and SERPINA12. Thorax 71(6), 501-509 (2016).
44. Soler Artigas M, Loth DW, Wain LV et al. Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat. Genet. 43(11), 1082-1090 (2011).
45. Hancock DB, Eijgelsheim M, Wilk JB et al. Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat. Genet. 42(1), 45-52 (2010).
46. Yao TC, Du G, Han L et al. Genome-wide association study of lung function phenotypes in a founder population. J. Allergy Clin. Immunol. 133(1), 248-255; e241-e210 (2014).
47. Li X, Hawkins GA, Ampleford EJ et al. Genome-wide association study identifies TH1 pathway genes associated with lung function in asthmatic patients. J. Allergy Clin. Immunol. 132(2), 313e315-320e315 (2013).
48. Hegab AE, Sakamoto T, Saitoh W et al. Polymorphisms of TNFalpha, IL1beta, and IL1RN genes in chronic obstructive pulmonary disease. Biochem. Biophys. Res. Commun. 329(4), 1246-1252 (2005).
49. Plate M, Lawson PJ, Hill MR et al. Impact of a functional polymorphism in the PAR-1 gene promoter in COPD and COPD exacerbations. Am. J. Physiol. Lung Cell Mol. Physiol. 307(4), L311-L316 (2014).
50. Lee SY, Kim MJ, Kang HG et al. Polymorphisms in matrix metalloproteinase-1, -9 and -12 genes and the risk of chronic obstructive pulmonary disease in a Korean population. Respiration 80(2), 133-138 (2010).
51. Qiu W, Cho MH, Riley JH et al. Genetics of sputum gene expression in chronic obstructive pulmonary disease. PLoS ONE 6(9), e24395 (2011).
52. Sun XX, He X, Yin L, Komada M, Sears RC, Dai MS. The nucleolar ubiquitin-specific protease USP36 deubiquitinates and stabilizes c-Myc. Proc. Natl Acad. Sci. USA 112(12), 3734-3739 (2015).
53. Hancock DB, Soler Artigas M, Gharib SA et al. Genomewide joint meta-analysis of SNP and SNP-by-smoking interaction identifies novel loci for pulmonary function. PLoS Genet. 8(12), e1003098 (2012).
54. Kim DK, Cho MH, Hersh CP et al. Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 186(12), 1238-1247 (2012).
55. Boucherat O, Morissette MC, Provencher S, Bonnet S, Maltais F. Bridging lung development with chronic obstructive pulmonary disease. Relevance of developmental pathways in chronic obstructive pulmonary disease pathogenesis. Am. J. Respir. Crit. Care Med. 193(4), 362-375 (2016).
56. Martinez FD. Early-life origins of chronic obstructive pulmonary disease. N. Engl. J. Med. 375(9), 871-878 (2016).
57. Wang J, Duncan D, Shi Z, Zhang B. WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013. Nucleic Acids Res. 41, W77-W83 (2013).
58. Manolio TA, Collins FS, Cox NJ et al. Finding the missing heritability of complex diseases. Nature 461(7265), 747-753 (2009).